News & Blog

Noninvasive blood glucose monitor

Monday 14th November 2016

JRBiomedical Ltd, the North Wales biotech company distributing the new VivaChek blood glucose meter in the UK, is to start a feasibility study in to the technical and commercial viability of a non-invasive blood glucose monitoring system for diabetics.

Currently, insulin dependent diabetics need to test their blood glucose levels several times a day using a lancet to produce a blood sample. Although the amount of blood required by blood glucose monitors, such as VivaChek, is only 0.5µL in volume, repeated use of lancets everyday can cause soreness and discomfort.

A simple device, that avoids the need for a blood sample would be a significant step forward in the management of diabetes with opportunities to increase patient compliance with testing and a potential to reduce the economic burden on the NHS for test strips and lancets.

The feasibility study is expected to last 12 months and start in Q1/2017.

We are asking the diabetes community including diabetics, DSN's, practice nurses and doctors to input in to the design of the new meter. If you would like to take part we would be grateful if you could complete this short questionnaire.

Updates will be posted on @JRBiomedical